Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in Germany

AIDS Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Anadol, E ^a   Beckebaum, S ^b   Radecke, K ^b   Paul, A ^b   Zoufaly, A ^c   Bickel, M ^d   Hitzenbichler, F ^e   Ganten, T ^f   Kittner, J ^g   Stoll, M ^h   Berg, C ⁱ   Manekeller, S ^a   Kalff, J C ^a   Sauerbruch, T ^a   Rockstroh, J K ^a   Spengler, U ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c UNIVERSITY OF HAMBURG   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e UNIVERSITY OF REGENSBURG   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g JOHANNES GUTENBERG UNIVERSITY   (Germany)

^h HANNOVER MEDICAL SCHOOL   (Germany)

ⁱ UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873615506     PISSN: 20901240     EISSN: 20901259     Source Type: Journal    
DOI: 10.1155/2012/197501     Document Type: Article

References (34)

1. Lee L. M., Karon J. M., Selik R., Neal J. J., Fleming P. L., Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984-1997. Journal of the American Medical Association 2001 285 10 1308 1315 2-s2.0-0035857768
2. Mocroft A., Ledergerber B., Katlama C., Kirk O., Reiss P., D'Arminio Monforte A., Knysz B., Dietrich M., Phillips A. N., Lundgren J. D., Decline in the AIDS and death rates in the EuroSIDA study: an observational study. The Lancet 2003 362 9377 22 29 2-s2.0-0038162585 10.1016/S0140-6736(03)13802-0
3. Rockstroh J. K., Spengler U., HIV and hepatitis C virus co-infection. Lancet Infectious Diseases 2004 4 7 437 444 2-s2.0-3042518936 10.1016/S1473-3099(04)01059-X
4. Konopnicki D., Mocroft A., De Wit S., Antunes F., Ledergerber B., Katlama C., Zilmer K., Vella S., Kirk O., Lundgren J. D., Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 2005 19 6 593 601 2-s2.0-20244373332
5. Bica I., McGovern B., Dhar R., Stone D., McGowan K., Scheib R., Snydman D. R., Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clinical Infectious Diseases 2001 32 3 492 497 2-s2.0-0035112776 10.1086/318501
6. Merchante N., Girón-González J. A., González-Serrano M., Torre-Cisneros J., García-García J. A., Arizcorreta A., Ruiz-Morales J., Cano-Lliteras P., Lozano F., Martínez-Sierra C., Macías J., Pineda J. A., Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 2006 20 1 49 57 2-s2.0-29144506134
7. Mindikoglu A. L., Regev A., Magder L. S., Impact of human immunodeficiency virus on survival after liver transplantation: analysis of united network for organ sharing database. Transplantation 2008 85 3 359 368 2-s2.0-40049109390 10.1097/TP.0b013e3181605fda
8. Miro M. M., Castells L., Meneu J., 5-year survival of HCV/HIV-co-infected liver transplant recipients: a case/control study. Proceedings of the 16th Conference on Retroviruses and Opportunistic Infections 2009 Montreal, Canada
9. Joshi D., Aluvihare V., Belgaumkar A., UK liver transplant experience of HIV: long term outcomes. Journal of Hepatology 2009 50 1 S23
10. Teicher E., Duclos Vallee J.-C., Samuel D., Liver transplantation in 88 HIV-infected patients. Proceedings of the 16th CROI Conference on Retroviruses and Opportunistic Infections 2009 Montreal, Canada
11. Unos, MELD/PELD calculator documentation. http://optn.transplant.hrsa. gov/resources/professionalResources.asp?index=8
12. Tan-Tam C. C., Frassetto L. A., Stock P. G., Liver and kidney transplantation in HIV-infected patients. AIDS Reviews 2009 11 4 190 204 2-s2.0-74249097832
13. Samuel D., Weber R., Stock P., Duclos-Vallée J. C., Terrault N., Are HIV-infected patients candidates for liver transplantation? Journal of Hepatology 2008 48 5 697 707 2-s2.0-40949161351 10.1016/j.jhep.2008.02.009
14. Ragni M. V., Belle S. H., Im K., Neff G., Roland M., Stock P., Heaton N., Humar A., Fung J. F., Survival of human immunodeficiency virus-infected liver transplant recipients. Journal of Infectious Diseases 2003 188 10 1412 1420 2-s2.0-0347275779 10.1086/379254
15. Vittecoq D., Teicher E., Merad M., Vallée J. D., Dussaix E., Samuel D., Liver transplantation is it possible in HIV/HCV co-infected patients? Pathologie Biologie 2003 51 8-9 525 527 2-s2.0-0142119180 10.1016/S0369- 8114(03)00172-X
16. Norris S., Taylor C., Muiesan P., Portmann B. C., Knisely A. S., Bowles M., Rela M., Heaton N., O'Grady J. G., Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection. Liver Transplantation 2004 10 10 1271 1278 2-s2.0-6444243484 10.1002/lt.20233
17. Moreno A., Cervera C., Fortn J., Epidemiology and outcome of infectins in HIV/HCV-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study. Liver Transplantation and Surgery 2012 18 1 70 81 10.1002/lt.22431
18. Duclos-Vallée J. C., Féray C., Sebagh M., Teicher E., Roque-Afonso A. M., Roche B., Azoulay D., Adam R., Bismuth H., Castaing D., Vittecoq D., Samuel D., Gigou M., Tateo M., Cailliez V., Dussaix E., Guettier C., Bralet M. P., Ichaï P., Saliba F., Antonini T., Vibert E., Veilhan L. A., Andreani P., Gillon M. C., Kullman L., Josse C., Mirand A., Lebrette M. G., Pialoux G., Benhamou Y., Botta D., Bourlière M., Goria O., Cessot G., Grimbert S., Zylberberg H., Cadranel J. F., Cordier F., Ouzan D., Duvoux C., Dhumeaux D., Cassuto P., Bentata M., Beaugrand M., Ganne-Carrié N., Jeantils V., Longuet P., Grangé J. D., Pol S., Gervais A., Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2008 47 2 407 417 2-s2.0-39549094460 10.1002/hep.21990
19. de Vera M. E., Dvorchik I., Tom K., Eghtesad B., Thai N., Shakil O., Marcos A., Demetris A., Jain A., Fung J. J., Ragni M. V., Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C. American Journal of Transplantation 2006 6 12 2983 2993 2-s2.0-33751182671 10.1111/j.1600-6143.2006.01546.x
20. Castells L., Esteban J. I., Bilbao I., Vargas V., Allende H., Ribera E., Piron M., Sauleda S., Len O., Pahissa A., Esteban R., Guardia J., Margarit C., Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients. Antiviral Therapy 2006 11 8 1061 1070 2-s2.0-33845653617
21. Antonini T. M., Sebagh M., Roque-Afonso A. M., Teicher E., Roche B., Sobesky R., Coilly A., Vaghefi P., Adam R., Vittecoq D., Castaing D., Samuel D., Duclos-Vallée J. C., Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation. American Journal of Transplantation 2011 11 8 1686 1695 2-s2.0-79961024700 10.1111/j.1600-6143.2011.03608.x
22. Wojcik K., Vogel M., Voigt E., Speidel N., Kalff J. C., Goldmann G., Oldenburg J., Sauerbruch T., Rockstroh J. K., Spengler U., Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort. AIDS 2007 21 10 1363 1365 2-s2.0-34250013077 10.1097/QAD.0b013e3280d5a79a
23. Beckebaum S., Cicinnati V. R., Zhang X., Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study. Transplantation Proceedings 2004 36 5 1489 1491 2-s2.0-7044269182 10.1016/j.transproceed.2004.10.001
24. Rockstroh J. K., Bhagani S., Benhamou Y., Bruno R., Mauss S., Peters L., Puoti M., Soriano V., Tural C., European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Medicine 2008 9 2 82 88 2-s2.0-38949125850 10.1111/j.1468-1293.2007.00535.x
25. Vogel M., Voigt E., Schäfer N., Goldmann G., Schwarz N., Kalff J. C., Sauerbruch T., Wolff M., Rockstroh J. K., Spengler U., Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the bonn cohort. Liver Transplantation 2005 11 12 1515 1521 2-s2.0-29744434264 10.1002/lt.20498
26. Berenguer J., Álvarez-Pellicer J., Martín P. M., López-Aldeguer J., Von-Wichmann M. A., Quereda C., Mallolas J., Sanz J., Tural C., Bellón J. M., González-García J., Miralles P., Álvarez E., Cosín J., López J. C., Sánchez-Conde M., Gutiérrez I., Ramírez M., Amer M., Arribas J. R., Montes M. L., Pascual J. F., Peña J. M., Cuellar S., Bustinduy M. J., Iribarren J. A., Rodríguez-Arrondo F., Moreno A., Moreno S., Hernando A., Pulido F., Rubio R., De Miguel J., Jou A., Clotet B., Ortega E., Martin A., Ortiz L., Callau P., Laguno M., Santos I., Barquilla E., Mahillo B., Moyano B., Aznar E., Esteban H., Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus. Hepatology 2009 50 2 407 413 2-s2.0-68949183159 10.1002/hep.23020
27. Terrault N. A., Carter J. T., Carlson L., Roland M. E., Stock P. G., Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation. Liver Transplantation 2006 12 5 801 807 2-s2.0-33646455746 10.1002/lt.20776
28. Joshi D., Aluvihare V., Belgaumkar A., Liver transplantation for HIV: analysis of outcomes suggest HIV/HCV co-infected patients have prohibitively poor survival at 5 years. Hepatology 2008 48 supplement 1 311
29. Stock P. G., Roland M. E., Evolving clinical strategies for transplantation in the HIV-positive recipient. Transplantation 2007 84 5 563 571 2-s2.0-34548735403 10.1097/01.tp.0000279190.96029.77
30. Coffin C. S., Stock P. G., Dove L. M., Berg C. L., Nissen N. N., Curry M. P., Ragni M., Regenstein F. G., Sherman K. E., Roland M. E., Terrault N. A., Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients. American Journal of Transplantation 2010 10 5 1268 1275 2-s2.0-77951219796 10.1111/j.1600-6143.2010.03070.x
31. Qurishi N., Kreuzberg C., Lüchters G., Effenberger W., Kupfer B., Sauerbruch T., Rockstroh J. K., Spengler U., Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection. The Lancet 2003 362 9397 1708 1713 2-s2.0-0344120830 10.1016/S0140-6736(03) 14844-1
32. Vogel M., Voigt E., Michaelis H. C., Sudhop T., Wolff M., Türler A., Sauerbruch T., Rockstroh J. K., Spengler U., Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients. Liver Transplantation 2004 10 7 939 944 2-s2.0-3242780965 10.1002/lt.20165
33. Tricot L., Teicher E., Peytavin G., Zucman D., Conti F., Calmus Y., Barrou B., Duvivier C., Fontaine C., Welker Y., Billy C., De Truchis P., Delahousse M., Vittecoq D., Salmon-Céron D., Safety and efficacy of raltegravir in hiv-infected transplant patients cotreated with immunosuppressive drugs. American Journal of Transplantation 2009 9 8 1946 1952 2-s2.0-67650941473 10.1111/j.1600-6143.2009.02684.x
34. Mauss S., Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their management. Journal of Hepatology 2006 44 supplement 1 S114 S118 2-s2.0-30144444473 10.1016/j.jhep.2005.11.024.